Amantadine-resistant influenza A in a nursing facility.

Keywords

Amantadine, Isolation (microbiology), Medicine, Outbreak, Nursing homes

References

• Occurrence of Adverse Effects and High Amantadine Concentrations With Influenza Prophylaxis in the Nursing HomeИван Николаевич Тюренков, Andrey Voronkov, Е. В. Петрова — 1990
• Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infectionRobert B. Belshe, M. H. Smith, Charles B. Hall — 1988
• An influenza outbreak due to A/USSR/77-like (H1N1) virus aboard a US Navy ship.Thomas G. Ksiazek, James G. Olson, George S. Irving — 1980
• Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.Robert B. Belshe, Betty Burk, Frances Newman — 1989
• Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.VICTOR W. HORADAM, JAMES G. SHARP, JERRY D. SMILACK — 1981
• Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.Peter D. Reuman, David I. Bernstein, Michael C. Keefer — 1989
• The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home.Nancy H. Arden — 1988
• Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine.P. Patriarca, NANCY H. ARDEN, JEFFREY P. KOPLAN — 1987
• Laboratory and epidemiologic assessment of a recent influenza B outbreakJames C. King, Connor J. Haugh, William D. Dupont — 1988
• Prophylactic amantadine dose and plasma concentration—effect relationships in healthy adultsFred Y. Aoki, H Grant Stiver, Daniel Sitar — 1985
• Infection control practices in Minnesota nursing homes.Kent Crossley — 1985
• Antibody induction by influenza vaccines in the elderly: a review of the literature.W.E.P. Beyer, A.M. Palache, Machteld Baljet — 1989
• Adverse Reactions to Amantadine Prophylaxis of Influenza in a Retirement HomeKurt C. Stange, Dana Little, Bernadette Blatnik — 1991
• Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virusS D Sears, M L Clements — 1987
• Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adultsFrederick G. Hayden, A Minocha, Daniel A. Spyker — 1985
• Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.Frederick G. Hayden, Robert B. Belshe, Richard D. Clover — 1989

Cited by

• Update on therapy of influenza and rhinovirus infections.Eurico Arruda, Frederick G. Hayden — 1996
• Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing HomeM. Schilling, Stefan Gravenstein, Paul J. Drinka — 2004
• Use of antiviral prophylaxis in influenza outbreaks in long term care facilities.Allison McGeer, Daniel Sitar, Susan Tamblyn — 2000
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).C B Bridges, Keiji Fukuda, N J Cox — 2001
• Respiratory viral infections in the elderlyJohn J. Treanor, Ann R. Falsey — 1999
• Prevention and treatment of influenza in immunocompromised patients.Frederick G. Hayden — 1997
• The Effect of DHEAS on Influenza Vaccination in Aging AdultsJohn Degelau, David R.P. Guay, Helen M. Hallgren — 1997
• WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCERichard L. Hodinka — 1997
• Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000Susan K. Bowles, Wayne Lee, Andrew E. Simor — 2002
• Amantadine susceptibility in influenza A virus isolates: determination methods and lack of resistance in a Canadian sample, 1991-94.Isabelle Prud’homme, Olga Zoueva, J Weber — 1997
• Influenza Outbreaks in Long-Term-Care Facilities: How Can We Do Better?Andrew E. Simor — 2002
• Antivirals for InfluenzaGhinwa Dumyati, Ann R. Falsey — 2002
• Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing HomeChristine Lee, Mark Loeb, Anne Phillips — 2000
• Small Interfering RNA Targeting M2 Gene Induces Effective and Long Term Inhibition of Influenza A Virus ReplicationHongyan Sui, Guangyu Zhao, Jian‐Dong Huang — 2009
• Influenza A virus outbreak in a neonatal intensive care unit.Flor M. Muñoz, Judith Campbell, Robert L. Atmar — 1999
• Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic reviewKaitlin Rainwater‐Lovett, Kevin Chun, Justin Lessler — 2013
• New approaches to the use of ribavirinChristopher T. Nelson, Janet A. Englund — 1996
• Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium.Frederick G. Hayden, Barbara S. Rollins, Lisa K. Madren — 1994
• Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.Charles Welliver — 2001
• Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.Peter M. Houck — 1995

Related papers

• [Anti-influenza A viral drug--amantadine].Issei Tokimatsu, M Nasu — 2000
• Amantadine for prophylaxis against influenza A.Mats Karlsson, Olle Reichard, Annika Linde — 1987
• Isolation of Amantadine-Resistant Influenza A Viruses (H3N2) from Patients following Administration of Amantadine in JapanJun Iwahashi, Katsuro Tsuji, Tetsuya Ishibashi — 2001
• AmantadineG. Hubsher, Mohamed Haider, Michael S. Okun — 2012
• Amantadine Neurotoxicity in a Pediatric Patient with Renal InsufficiencyDawn K. Strong, David D. Eisenstat, Scott Bryson — 1991
• Combined treatment of parkinsonism with L-dopa and amantadine.R B Godwin-Austen, C. C. Frears, S. Bergmann — 1970
• Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.André Barbeau, Harold Mars, Mihai I. Botez — 1971
• NURSING HOME QUALITY IMPROVEMENT: ROLES AND INVOLVEMENT OF NURSING HOME LEADERS2015